Precocious puberty is a common cause for addressing pediatric patients in endocrinology offices, a prevalence that can be significantly influenced by environmental factors. According to studies, these factors have an impact even in the intrauterine life. Diet, especially from a qualitative point of view, defines one of the risk factors for precocious puberty and the most easily modifiable. We consider it useful to bring up the characteristics of precocious puberty and the multiple repercussions that affect both physical and mental development, with the mention that, in the absence of a prompt diagnosis and correctly performed to lead to an effective therapeutic management, these children are prone to chronic pathologies, but also to stigmatization, in the collectivities they belong to.
Pubertatea precoce reprezintă o cauză frecventă de adresabilitate a pacienţilor pediatrici în cabinetele de endocrinologie, prevalenţă ce poate fi semnificativ influenţată de factorii de mediu. Conform studiilor, aceşti factori au impact încă din viaţa intrauterină. Alimentaţia, mai ales din punct de vedere calitativ, este unul dintre factorii de risc pentru pubertatea precoce şi cel mai uşor modificabil. Considerăm util să aducem în discuţie caracteristicile pubertăţii precoce şi repercusiunile multiple, atât asupra dezvoltării fizice, cât şi psihice, cu menţiunea că, în lipsa unui diagnostic prompt şi corect efectuat, care să conducă spre un management terapeutic eficient, aceşti copii sunt predispuşi la patologii cronice, dar şi la stigmatizare, în colectivităţile din care fac parte.
Puberty is defined as the bridge between childhood and adulthood, a complex process that comes with multiple physical and mental changes, difficult to manage both by the new teenager and by the family. It is important that puberty takes place at the chronological age, so that the child is also psychologically prepared for this stage that is so important for the adult of tomorrow.
We are talking about precocious puberty in the presence of secondary sexual characteristics installed in females under 8 years of age or menarche under 10 years of age, and in the case of males, the appearance of secondary sexual characteristics at less than 9 years of age(1-3). Relative to the standard deviation of the mean, central precocious puberty (CPP) is present at the time of the onset of secondary sex characteristics faster than 2 to 2.5 standard deviations, while puberty refers to the development of the mammary gland in girls and the increase in size of the testicles in boys(4,5).
Depending on the etiology, we can have central and peripheral precocious puberty, the object of our work being central precocious puberty which is also called gonadotropin-dependent puberty due to the fact that GnRHa therapy is necessary(6). Central precocious puberty accounts for about 80% of all cases of precocious puberty and occurs due to the early activation of the hypothalamus-pituitary-gonadal axis. It is worth mentioning that the ratio of girls/boys for this form of puberty is 10/1, which makes us direct our current research exclusively to the female sex(6,7).
Precocious puberty
The etiology of central precocious puberty is multiple and heterogeneous, with possible congenital or acquired causes, regardless of the cause, and the onset of central precocious puberty is due to the premature reactivation of the hypothalamic-pituitary-gonadal axis caused by a premature secretion of hypothalamic GnRH(8,9).
The importance of environmental factors in the early onset of puberty was clearly defined with the help of the pandemic, when numerous studies reported increases in CPP globally. Thus, between April 2020 and April 2021, 2.5 times more cases of CPP were recorded in the pediatric endocrinology outpatient clinic of the University of Campania Luigi Vanvitelli than in the period 2017-2020, the main comorbidities identified being Body Mass Index (BMI) changes and sleep disorders(10,11).
A report from China revealed a three-fold increase in the number of CPP cases in 2020 compared to 2019, noting that the BMI of diagnosed girls was significantly higher in 2020. In addition to weight gain, processed food, reduced physical exertion, vitamin D deficiency and the long time allocated to electronic devices are the factors favoring this significant increase in cases of CPP(12).
A three-fold increase was also recorded in Turkey between 2020 and 2021, compared to the 2019-2020 period, and 69% of girls with rapidly progressive early puberty were overweight or obese(13).
It is unanimously accepted that, in addition to improper nutrition, overweight or obesity, psychological stress also intervenes in the onset of central precocious puberty, along with sedentary lifestyle, lack of sufficient quantitative or non-qualitative sleep and vitamin D deficiency, and all these factors were very well highlighted during the COVID-19 pandemic(14-17).
The negative effects of the installation of CPP are multiple and act multisystemically. The risk of breast and uterine cancer is higher among girls with central precocious puberty, according to studies, and the early onset of menarche and breasts can lead to serious disorders in the psychiatric sphere, ranging from depression of varying degrees, anxiety, low self-esteem and non-responsible sexual behaviors to low bone mineralization, type 2 diabetes and cardiovascular diseases, installed in adulthood, with the mention that we can find an advanced bone age without precocious puberty(1,18-23).
Due to the fact that precocious puberty is a common indication for sending a child to a doctor specialized in endocrinology, especially on an outpatient basis, and also the short- and long-term complications that can occur in the absence of a diagnosis and prompt treatment, along with the need for a multidisciplinary team of specialists, we consider it useful for the professionals in the field to provide an update on the management of central precocious puberty.
Diagnosis and treatment of central precocious puberty
The diagnosis of PPC is made based on a thorough anamnesis, complete physical examination, along with investigations for bone age, the most important of which are the dosage of sex hormones and the radiological examination. In the anamnesis, it is important to focus on the onset of puberty in case of the parents, genetics also playing an important role; the moment when the first pubertal changes were triggered, exposure to sex steroids, and the presence or absence of symptoms in the central nervous system (CNS) sphere (headaches, visual disturbances, seizures)(24,25).
During the physical examination, attention should be focused on anthropometric measurements and the evaluation of secondary sexual characteristics, according to the Marshall and Tanner classification (Figure 1)(26,27). In addition to these major indicators, the redistribution of adipose tissue on the hips, the growth of labia majora and minora, vaginal discharge, facial acne or axial hair are also indicators of the onset of puberty, with the mention that axial or pubic hair as the only sign is not a sign of precocious puberty, there being isolated pubarche or even thelarche, without evolution to precocious puberty(24,28).
In a first phase, the evaluation of sex steroids and serum basal gonadotropins is vital to establish the correct diagnosis, the gold standard being represented by the performance of the GnRH stimulation test, or using the synthetic analogue triptorelin. In radiological exploration, a bone age greater than 2.5 SD is significantly associated with CPP. It should be noted that, in the presence of a normal bone age, we should not exclude the diagnosis of central precocious puberty(24,29).
To rule out CNS damage, which are common causes of CPP, some studies indicate MRI, a controversial investigation when we talk about girls aged 6 to 8 years old, because central precocious puberty caused by CNS damage sets in much earlier, under the age of 6 years old, and predominates in males(30,31).
Genetic analysis is suggested in the presence of two or more family members with a definite diagnosis of PPC or other signs suggestive of the presence of genetic pathologies(32,33).
In the management of central precocious puberty, preparations of GnRH depot form are used, GnRHa being the gold standard in the therapeutic management of CPP, with safety and efficacy proven over the years, being well tolerated(6,8,34). The main target of GnRHa therapy is to slow down pubertal progression. We need this slowdown to achieve an appropriate increase in height. In addition to this aspect, we must not omit the reduction of the undesirable effects on physical and mental health caused by the aforementioned untreated CPP. The most common side effects are allergic reactions, hot flashes or seizures. There are studies that support weight gain under GnRHa therapy which then remits after stopping the treatment, while others support weight gain only in underweight girls or some that do not associate GnRHa therapy with an increased BMI(35-39).
The timing of when GnRHa treatment should be discontinued is also debated between the average age at which puberty sets in and the bone age of about 12 years(40).
The decision to initiate or stop GnRHa therapy requires careful, individualized analysis and family preferences.
The role of nutrition in the appearance of CPP
Nutrition plays an important role when puberty sets in. Therefore, specialized studies draw attention to the fact that nutrition is important to you from the preconception stage, just like in obesity. The next important stage is the period of pregnancy. Studies associate maternal excess weight with a high birth weight, and this correlates in the long term with a low age of onset of puberty(41-43). Not only the maternal BMI value plays a role in the onset of central precocious puberty, but also the composition of the diet; thus, phytoestrogens are identified as risk factors for CPP, such as isoflavones and lignans. Two important groups of phytoestrogens are found in soybeans, seeds, cereals and some fruits, with the possibility of crossing the placental barrier. Taking foods high in steroid hormones or extortionists, phytoestrogens can also be a cause for the onset of peripheral precocious puberty or precocious pseudopuberty(44-47).
Feeding exclusively with breast milk during the first six months is a benefit for an onset of puberty at an older age, and thus to avoid central precocious puberty. When we talk about formula feeding, their role in determining CPP is different and, contrary to the debate in the specialized medical world, the basis from which the formula is made matters; but, regardless of the content, they tend to have a higher protein intake than mother’s milk, which over time leads to weight gain and a BMI above normal values, being a risk factor for CPP(20).
Diversification initiated at the right age and in compliance with the nutritional recommendations in force is recommended. A balance between macro- and micronutrients is essential for a good development. Proteins are an essential category of macronutrients in the development of the child, contributing to the formation of tissues; however, a high intake of proteins accelerates the onset of puberty, which leads to an increase in the secretion of adrenal androgens(48,49).
Lipids are essential in the CNS myelination process, with a role in the absorption of fat-soluble vitamins, being a category of macronutrients that provide an important source of energy. When consumed in excess, they can lead to the installation of CPP through their actions on estrogen metabolism. Also, polyunsaturated fatty acids (PUFA), with direct effects on steroidogenesis and the development of the mammary glands, lead to the installation of central precocious puberty(49-51).
Carbohydrates are the main source of energy, essential macronutrients for the feeling of satiety, to prevent constipation, with indispensable functions in the normal functioning of cells(50,52).
A high weight in childhood has also been linked to an onset of CPP and early menarche(53-55). Thus, nutrition is important throughout life and, when balanced, is a protective factor for multiple pathologies.
Discussion
The increasingly early installation of central precocious puberty is an alarming sign; globally, there has been an increase in the percentages of CPP in recent years. In South Korea, there was an increase from 89.4 to 415.3 per 100,000 girls under the age of 9 from 2008 to 2014(56).
A rising prevalence for females was also reported in a six-year study in Korea, where a prevalence of 57.6 per 100,000 was identified, with a female/male ratio of 55.9 to 1.7 and with an incidence rate of 15.9 per 100,000 (15.3 females and 0.6 males)(4,57).
The Cebu Longitudinal Health and Nutrition Survey revealed a 6% decrease in the risk of developing CPP for each month of exclusive breastfeeding, the beneficial effect of breastfeeding in preventing central precocious puberty being shown by several studies. Thus, Lee et al. demonstrate that exclusive breastfeeding for six months is associated with lower rates of developing CPP versus exclusive breastfeeding for less than six months, based on an analysis conducted on a group of 219 children(58,59). Also, in a study conducted in the UK, an association was found between exclusive breastfeeding and the older age of menarche(60).
The feeding of soy products to the child is a controversial issue. There are studies that support the negative impact of soy consumption and associate it with the onset of CPP. A higher level of urinary isoflavones in girls with precocious puberty compared to the control group has been identified in numerous specialized studies(4,61). There are also studies that have not identified a correlation between soy intake and the onset of CPP, therefore we consider that future studies are needed on this topic(62,63).
Early diversification, before the age of 6 months old, leads to overweight, which, as mentioned before, is a risk factor for central precocious puberty, and the incorrect diversification, without taking into account the recommendations of medical staff, will have the same effect of increasing energy intake(64).
According to specialists, the toddler’s diet should be balanced and adapted to the child’s age, without snacks rich in simple sugars and junk-foods, with the mention that many studies consider nutrition during this period a modifiable variable for CPP(65).
Berkey et al. demonstrated that a protein intake of more than 8 grams/day leaded to a 0.6 year delay in the onset of puberty, a claim also supported by research conducted by Gunther et al.(66,67)
The Avon Longitudinal Study supports the claim of the two researchers, showing in their study an association between increased protein intake in the prepubertal period and the lower age of onset of puberty(68).
Excess protein intake was also associated with the onset of CPP in a study of adolescent girls in China, and an adequate fruit and vegetable intake was found to be a protective factor. Of note, the role of protein in the proper development of children and adolescents is vital, but the quantity and quality of protein, in turn, can be harmful – especially an increased consumption of red meat. Under these conditions, a consumption of red meat greater than or equal to two servings per day was associated with 64% increased chances to develop CPP(56).
Zinc – a micronutrient with multiple roles, including supporting the immune system, maintaining fertility and regulating metabolism – when taken as a supplement, leads to the development of CPP(69).
Childhood obesity is a risk factor for central precocious puberty, through hyperandrogenemia and insulin resistance that develops(57). In a review of eighty-two studies or case reports to identify the causes of the onset of CPP, genetic, pediatric and ethnic obesity accounted for three of the six identified causes, along with psychosocial stress, early exposure to a sexualized society, and environmental toxins(70).
The lipid levels were significantly elevated in girls with CPP compared to the control group, and the increased triglycerides present in the 1023 girls, from a total of 14 studies, draw attention to the risk of cardiovascular diseases to which these future young adults will be exposed far too early. By an early prevention of obesity, preferably from the preconception stage, we will reduce the prevalence of obesity, along with the multitude of chronic noncommunicable diseases that are installed due to an excess of adipose tissue in the body(71).
An ultrasonographic analysis of 1977 girls, where the length of the uterus was measured, raised the possibility of using the length of the uterus in the differential diagnosis between CPP and early thelarche, with the mention that a length of 3.2 cm or more may be a diagnostic marker of puberty(72-74).
The unbalanced lifestyle brought by the COVID-19 pandemic has led to an increase in the number of cases of central precocious puberty reported worldwide, thus clearly highlighting the importance of external risk factors, such as stress, lack of physical exertion, excessive time spent on gadgets and poor nutrition in the development of CPP(75-77).
We can affirm that a balanced lifestyle with adequate macronutrient and micronutrient nutrition, along with regular physical exercise, limitation of screen time and a good psychological mood will contribute to the physical and mental health necessary for a normal nutritional status and prevent the onset of CPP, a statement also supported by Fu et al. in a report of the analysis of central precocious puberty during the COVID-19 pandemic(12).
Conclusions
Puberty is considered to be the bridge between childhood and adulthood, with numerous repercussions on the physical and mental health of the future adult.
Nutrition is a modifiable risk factor in the onset of precocious puberty. It also has an essential role for the proper development of the adolescent. For this reason, we draw attention to the need for nutritional education programs that should start at an early age.
We believe that it is the role and duty of us, the medical personnel who interact with the pediatric population, to prevent, early identify and appropriately treat cases of central precocious puberty.
Autor corespondent: Heidrun Adumitrăchioaiei E-mail: ad.heidi91@gmail.com
CONFLICT OF INTEREST: none declared.
FINANCIAL SUPPORT: none declared.
This work is permanently accessible online free of charge and published under the CC-BY.
Bibliografie
Dong Y, Dai L, Dong Y, et al. Analysis of risk factors of precocious puberty in children [published correction appears in BMC Pediatr. 2023 Sep 22;23(1):482. doi: 10.1186/s12887-023-04320-7]. BMC Pediatr. 2023;23(1):456.
Han XX, Zhao FY, Gu KR, et al. Development of precocious puberty in children: Surmised medicinal plant treatment. Biomed Pharmacother Biomedecine Pharmacother. 2022;156:113907.
Roberts SA, Kaiser UB. Genetics in Endocrinology: Genetic etiologies of central precocious puberty and the role of imprinted genes. Eur J Endocrinol. 2020;183(4):R107-R117.
Kim SJ, Kim JH, Hong YH, et al. 2022 Clinical practice guidelines for central precocious puberty of Korean children and adolescents. Ann Pediatr Endocrinol Metab. 2023;28(3):168-177.
Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969;44(235):291-303.
Ergun-Longmire B, Vining-Maravolo P, Graham B, Greydanus DE. A narrative review: treatment outcomes of central precocious puberty (CPP). Pediatr Med. 2023;6(0).
Soriano-Guillén L, Corripio R, Labarta JI, et al. Central precocious puberty in children living in Spain: incidence, prevalence, and influence of adoption and immigration.
J Clin Endocrinol Metab. 2010;95(9):4305-4313.
Carel JC, Eugster EA, Rogol A, et al. Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics. 2009;123(4):e752-762.
Hou L, Ying Y, Wu W, Ye F, Zhang C, Luo X. The effect of GnRHa treatment on BMI in central precocious puberty: A systematic review and meta-analysis. Horm Res Paediatr. Published online January 5, 2024. doi:10.1159/000535132,
Prosperi S, Chiarelli F. Early and precocious puberty during the COVID-19 pandemic. Front Endocrinol. 2023;13:1107911.
Umano GR, Maddaluno I, Riccio S, et al. Central precocious puberty during COVID-19 pandemic and sleep disturbance: an exploratory study. Ital J Pediatr. 2022;48(1):60.
Fu D, Li T, Zhang Y, et al. Analysis of the Incidence and Risk Factors of Precocious Puberty in Girls during the COVID-19 Pandemic. Int J Endocrinol. 2022;2022(1):9229153.
Acinikli KY, Erbaş İM, Besci Ö, Demir K, Abacı A, Böber E. Has the Frequency of Precocious Puberty and Rapidly Progressive Early Puberty Increased in Girls During the COVID-19 Pandemic? J Clin Res Pediatr Endocrinol. 2022;14(3):302-307.
Trott M, Driscoll R, Irlado E, Pardhan S. Changes and correlates of screen time in adults and children during the COVID-19 pandemic: A systematic review and meta-analysis. EClinicalMedicine. 2022;48:101452.
Shneor E, Doron R, Levine J, et al. Objective Behavioral Measures in Children before, during, and after the COVID-19 Lockdown in Israel. Int J Environ Res Public Health. 2021;18(16):8732.
Liu S, Zhu X, Wang Y, Yan S, Li D, Cui W. The association between vitamin D levels and precocious puberty: a meta-analysis. J Pediatr Endocrinol Metab. 2020;33(3):427-429.
Murcia García J, Muñoz Hoyos A, Molina Carballo A, Fernández García JM, Narbona López E, Uberos Fernández J. Pubertad y melatonina. An Pediatría. 2002;57(2):121-126.
Mendle J, Turkheimer E, Emery RE. Detrimental psychological outcomes associated with early pubertal timing in adolescent girls. Dev Rev. 2007;27(2):151-171.
Ge X, Conger RD, Elder GH. Coming of age too early: pubertal influences on girls’ vulnerability to psychological distress. Child Dev. 1996;67(6):3386-3400.
Calcaterra V, Verduci E, Magenes VC, et al. The Role of Pediatric Nutrition as a Modifiable Risk Factor for Precocious Puberty. Life. 2021;11(12):1353.
Elks CE, Ong KK, Scott RA, et al. Age at menarche and type 2 diabetes risk: the EPIC-InterAct study. Diabetes Care. 2013;36(11):3526-3534.
Prentice P, Viner RM. Pubertal timing and adult obesity and cardiometabolic risk in women and men: a systematic review and meta-analysis. Int J Obes (Lond). 2013;37(8):1036-1043.
Day FR, Elks CE, Murray A, Ong KK, Perry JRB. Puberty timing associated with diabetes, cardiovascular disease and also diverse health outcomes in men and women: the UK Biobank study. Sci Rep. 2015;5:11208.
Wood CL, Lane LC, Cheetham T. Puberty: Normal physiology (brief overview). Best Pract Res Clin Endocrinol Metab. 2019;33(3):101265.
Papanikolaou A, Michala L. Autonomous Ovarian Cysts in Prepubertal Girls. How Aggressive Should We Be? A Review of the Literature. J Pediatr Adolesc Gynecol. 2015;28(5):292-296.
Tauber M, Hoybye C. Endocrine disorders in Prader-Willi syndrome: a model to understand and treat hypothalamic dysfunction. Lancet Diabetes Endocrinol. 2021;9(4):235-246.
Tinano FR, Canton APM, Montenegro LR, et al. Clinical and Genetic Characterization of Familial Central Precocious Puberty. J Clin Endocrinol Metab. 2023;108(7):1758-1767.
Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med. 1991;325(24):1688-1695.
Głąb E, Wikiera B, Bieniasz J, Barg E. The Influence of GnRH Analog Therapy on Growth in Central Precocious Puberty. Adv Clin Exp Med Off Organ Wroclaw Med Univ. 2016;25(1):27-32.
Cantas-Orsdemir S, Eugster EA. Update on central precocious puberty: from etiologies to outcomes. Expert Rev Endocrinol Metab. 2019;14(2):123-130.
Bangalore Krishna K, Fuqua JS, Rogol AD, et al. Use of Gonadotropin-Releasing Hormone Analogs in Children: Update by an International Consortium. Horm Res Paediatr. 2019;91(6):357-372.
Bertelloni S, Mul D. Treatment of central precocious puberty by GnRH analogs: long-term outcome in men. Asian J Androl. 2008;10(4):525-534.
Bertelloni S, Baroncelli GI. Current pharmacotherapy of central precocious puberty by GnRH analogs: certainties and uncertainties. Expert Opin Pharmacother. 2013;14(12):1627-1639.
Kaplowitz PB, Backeljauw PF, Allen DB. Toward More Targeted and Cost-Effective Gonadotropin-Releasing Hormone Analog Treatment in Girls with Central Precocious Puberty. Horm Res Paediatr. 2018;90(1):1-7.
Lee SJ, Yang EM, Seo JY, Kim CJ. Effects of gonadotropin-releasing hormone agonist therapy on body mass index and height in girls with central precocious puberty. Chonnam Med J. 2012;48(1):27-31.
Onat PŞ, Erdeve ŞS, Çetinkaya S, Aycan Z. Effect of gonadotropin-releasing hormone analog treatment on final height in girls aged 6-10 years with central precocious and early puberty. Turk Pediatri Arsivi. 2020;55(4):361-369.
Paterson WF, McNeill E, Young D, Donaldson MD. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty. Clin Endocrinol (Oxf). 2004;61(5):626-634.
Vuralli D, Ozon ZA, Gonc EN, Alikasifoglu A, Kandemir N. Long-term effects of GnRH agonist treatment on body mass index in girls with idiopathic central precocious puberty. J Pediatr Endocrinol Metab JPEM. 2020;33(1):99-105.
Hou L, Ying Y, Wu W, Ye F, Zhang C, Luo X. The effect of GnRHa treatment on BMI in central precocious puberty: A systematic review and meta-analysis. Horm Res Paediatr. Published online January 5, 2024.
Micangeli G, Paparella R, Tarani F, et al. Clinical Management and Therapy of Precocious Puberty in the Sapienza University Pediatrics Hospital of Rome, Italy. Child Basel Switz. 2023;10(10):1672.
Diemert A, Lezius S, Pagenkemper M, et al. Maternal nutrition, inadequate gestational weight gain and birth weight: results from a prospective birth cohort. BMC Pregnancy Childbirth. 2016;16:224.
Voerman E, Santos S, Patro Golab B, et al. Maternal body mass index, gestational weight gain, and the risk of overweight and obesity across childhood: An individual participant data meta-analysis. PLoS Med. 2019;16(2):e1002744.
Poston L. Maternal obesity, gestational weight gain and diet as determinants of offspring long term health. Best Pract Res Clin Endocrinol Metab. 2012;26(5):627-639.
Marks KJ, Hartman TJ, Taylor EV, Rybak ME, Northstone K, Marcus M. Exposure to phytoestrogens in utero and age at menarche in a contemporary British cohort. Environ Res. 2017;155:287-293.
Kim SH, Park MJ. Effects of phytoestrogen on sexual development. Korean J Pediatr. 2012;55(8):265-271.
Todaka E, Sakurai K, Fukata H, et al. Fetal exposure to phytoestrogens - The difference in phytoestrogen status between mother and fetus. Environ Res. 2005;99(2):195-203.
Foster WG, Chan S, Platt L, Hughes CL. Detection of phytoestrogens in samples of second trimester human amniotic fluid. Toxicol Lett. 2002;129(3):199-205.
Remer T, Shi L, Buyken AE, Maser-Gluth C, Hartmann MF, Wudy SA. Prepubertal adrenarchal androgens and animal protein intake independently and differentially influence pubertal timing. J Clin Endocrinol Metab. 2010;95(6):3002-3009.
Calcaterra V, Cena H, Regalbuto C, et al. The Role of Fetal, Infant, and Childhood Nutrition in the Timing of Sexual Maturation. Nutrients. 2021;13(2):419.
Nguyen AN, Santos S, Braun KVE, Voortman T. Carbohydrate Intake in Early Childhood and Body Composition and Metabolic Health: Results from the Generation R Study. Nutrients. 2020;12(7):1940.
Anderson BM, MacLennan MB, Hillyer LM, Ma DWL. Lifelong exposure to n-3 PUFA affects pubertal mammary gland development. Appl Physiol Nutr Metab Physiol Appl Nutr Metab. 2014;39(6):699-706.
Stephen A, Alles M, de Graaf C, et al. The role and requirements of digestible dietary carbohydrates in infants and toddlers. Eur J Clin Nutr. 2012;66(7):765-779.
Juul F, Chang VW, Brar P, Parekh N. Birth weight, early life weight gain and age at menarche: a systematic review of longitudinal studies. Obes Rev. 2017;18(11):1272-1288.
Kwok MK, Schooling CM, Lam TH, Leung GM. Does breastfeeding protect against childhood overweight? Hong Kong’s “Children of 1997” birth cohort. Int J Epidemiol. 2010;39(1):297-305.
Karaolis-Danckert N, Buyken AE, Sonntag A, Kroke A. Birth and early life influences on the timing of puberty onset: results from the DONALD (DOrtmund Nutritional and Anthropometric Longitudinally Designed) Study. Am J Clin Nutr. 2009;90(6):1559-1565.
Gu Q, Wu Y, Feng Z, et al. Dietary pattern and precocious puberty risk in Chinese girls: a case-control study. Nutr J. 2024;23(1):14.
Kim SH, Huh K, Won S, Lee KW, Park MJ. A Significant Increase in the Incidence of Central Precocious Puberty among Korean Girls from 2004 to 2010. PloS One. 2015;10(11):e0141844.
Al-Sahab B, Adair L, Hamadeh MJ, Ardern CI, Tamim H. Impact of breastfeeding duration on age at menarche. Am J Epidemiol. 2011;173(9):971-977.
Lee HA, Kim YJ, Lee H, et al. The preventive effect of breast-feeding for longer than 6 months on early pubertal development among children aged 7-9 years in Korea. Public Health Nutr. 2015;18(18):3300-3307.
Morris DH, Jones ME, Schoemaker MJ, Ashworth A, Swerdlow AJ. Determinants of age at menarche in the UK: analyses from the Breakthrough Generations Study. Br J Cancer. 2010;103(11):1760-1764.
Yum T, Lee S, Kim Y. Association between precocious puberty and some endocrine disruptors in human plasma. J Environ Sci Health Part A. 2013;48(8):912-917.
Giampietro PG, Bruno G, Furcolo G, et al. Soy protein formulas in children: no hormonal effects in long-term feeding. J Pediatr Endocrinol Metab. 2004;17(2):191-196.
Sinai T, Ben-Avraham S, Guelmann-Mizrahi I, et al. Consumption of soy-based infant formula is not associated with early onset of puberty. Eur J Nutr. 2019;58(2):681-687.
Thompson AL, Bentley ME. The critical period of infant feeding for the development of early disparities in obesity. Soc Sci Med. 2013;97:288-296.
Chen C, Chen Y, Zhang Y, et al. Association between Dietary Patterns and Precocious Puberty in Children: A Population-Based Study. Int J Endocrinol. 2018;2018:4528704.
Günther ALB, Karaolis-Danckert N, Kroke A, Remer T, Buyken AE. Dietary protein intake throughout childhood is associated with the timing of puberty. J Nutr. 2010;140(3):565-571.
Berkey CS, Gardner JD, Frazier AL, Colditz GA. Relation of childhood diet and body size to menarche and adolescent growth in girls. Am J Epidemiol. 2000;152(5):446-452.
Boyd A, Golding J, Macleod J, et al. Cohort Profile: the ‘children of the 90s’ - the index offspring of the Avon Longitudinal Study of Parents and Children. Int J Epidemiol. 2013;42(1):111-127.
Jansen EC, Marín C, Mora-Plazas M, Villamor E. Higher Childhood Red Meat Intake Frequency Is Associated with Earlier Age at Menarche. J Nutr. 2015;146(4):792-798.
Cesario SK, Hughes LA. Precocious puberty: a comprehensive review of literature.
J Obstet Gynecol Neonatal Nurs JOGNN. 2007;36(3):263-274. d
Jiang M, Gao Y, Wang K, Huang L. Lipid profile in girls with precocious puberty: a systematic review and meta-analysis. BMC Endocr Disord. 2023;23(1):225.
Sathasivam A, Rosenberg HK, Shapiro S, Wang H, Rapaport R. Pelvic ultrasonography in the evaluation of central precocious puberty: comparison with leuprolide stimulation test. J Pediatr. 2011;159(3):490-495.
Wen X, Wen D, Zhang H, Zhang H, Yang Y. Observational study pelvic ultrasound a useful tool in the diagnosis and differentiation of precocious puberty in Chinese girls. Medicine (Baltimore). 2018;97(10):e0092.
Nguyen NN, Huynh LBP, Do MD, Yang TY, Tsai MC, Chen YC. Diagnostic Accuracy of Female Pelvic Ultrasonography in Differentiating Precocious Puberty from Premature Thelarche: A Systematic Review and Meta-analysis. Front Endocrinol. 2021;12:735875.
Al Hourani H, Alkhatib B, Abdullah M. Impact of COVID-19 Lockdown on Body Weight, Eating Habits, and Physical Activity of Jordanian Children and Adolescents. Disaster Med Public Health Prep. 2022;16(5):1855-1863.
Pujia R, Ferro Y, Maurotti S, et al. The Effects of COVID-19 on the Eating Habits of Children and Adolescents in Italy: A Pilot Survey Study. Nutrients. 2021;13(8):2641.
Androutsos O, Perperidi M, Georgiou C, Chouliaras G. Lifestyle Changes and Determinants of Children’s and Adolescents’ Body Weight Increase during the First COVID-19 Lockdown in Greece: The COV-EAT Study. Nutrients. 2021;13(3):930.